Back to search
Final results of a phase II study of erlotinib, docetaxel and cisplatin in patients with recurrent/metastatic head and neck cancer
Data up to Jan 2025
Published2007
Citations51
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
No citing papers found in database